Variable | Subcategory | Na | Average ± SDb | Min | Max | Range |
Temperature (Celsius) | Max | 110 | 37.23 ± 0.47 | 36.5 | 40 | 3.5 |
Min | 106 | 36.27 ± 0.46 | 34.2 | 37.4 | 3.2 | |
L3Ac | 106 | 36.69 ± 0.26 | 36.2 | 37.4 | 1.2 | |
Blood Pressure (mmHg) | Systolic L3A | 113 | 114.88 ± 12.35 | 93.33 | 150 | 56.7 |
Diastolic L3A | 113 | 71.86 ± 9.11 | 53.33 | 110 | 56.7 | |
Respiratory Rate (per minute) | Max | 107 | 21.07 ± 4.76 | 15 | 46 | 31 |
L3A | 105 | 18.01 ± 1.09 | 15 | 20.5 | 5.5 | |
Oxygen Saturation (%) | Assisted Oxygenation L3A | 81 | 95.28 ± 2.85 | 81 | 99.7 | 18.7 |
Passive Oxygenation Max | 101 | 93.33 ± 3.71 | 82 | 100 | 18 | |
Passive Oxygenation Min | 106 | 86.18 ± 7.2 | 52 | 98 | 46 | |
Passive Oxygenation L3A | 99 | 90.82 ± 4.83 | 73 | 98 | 25 | |
Baseline | 111 | 85.44 ± 10.85 | 42 | 98 | 56 | |
CT Scan Lung Involvement | Extent (%) | 119 | 35.97 ± 16.83 | 5 | 75 | 70 |
Variable | Subcategory | n | Count | Ratio (%)d | ||
CT Scan Lung Involvement Appearance | Ground Glass Opacities (GGO) | 119 | 63 | 52.9 | ||
Consolidations | 7 | 5.9 | ||||
Atelectasis | 5 | 4.2 | ||||
Nodular | 4 | 3.4 | ||||
Embolic | 1 | 0.8 | ||||
GGO + Consolidations | 18 | 15.1 | ||||
GGO + Atelectasis | 9 | 7.6 | ||||
GGO + Embolic | 8 | 6.7 | ||||
GGO + Nodular | 4 | 3.4 | ||||
Significant Medical History Items | Hypertension | 122 | 41 | 33.6 | ||
Diabetes Mellitus | 16 | 13.1 | ||||
Neoplasm (in remission) | 14 | 11.5 | ||||
Chronic Obstructive Pulmonary Disease | 13 | 10.7 | ||||
End-Stage Renal disease | 10 | 8.2 | ||||
Coronary Artery Disease | 10 | 8.2 | ||||
Autoimmune Disorder | 10 | 8.2 | ||||
Hypothyroidism | 7 | 5.7 | ||||
Asthma | 6 | 4.9 | ||||
Cerebrovascular Accident | 5 | 4.1 | ||||
Chronic Kidney Disease | 4 | 3.3 | ||||
Smoking | Yes | 111 | 30 | 27 | ||
Former | 3 | 2.7 | ||||
No | 78 | 70.3 | ||||
COVID-19 Associated Organ Involvement | Liver | 122 | 17 | 13.9 | ||
Hemato/Vascular | 10 | 8.2 | ||||
Kidney | 7 | 5.7 | ||||
Multiple Organs | 8 | 6.5 | ||||
ICU Admission | Yes | 122 | 27 | 22.1 | ||
No | 95 | 77.9 | ||||
Adverse Event | Yes | 122 | 34 | 27.9 | ||
No | 88 | 72.1 | ||||
COVID-19 Severity | Mild to Moderate | 122 | 66 | 54.1 | ||
Severe to Critical | 56 | 45.9 | ||||
Periodontitis Severity | Healthy / Localized Mild Gingivitis | 122 | 37 | 30.3 | ||
Generalized Stage I or II | 42 | 34.4 | ||||
Generalized Stage III or IV | 43 | 35.2 |